Physician profile
George Bugarinovic
NPI 1366062770
$9,959.06
in general payments reported to CMS, 2019-2025
8 companies · $2,840 in 2025
The $2,840 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,696 · 2021: $1,225 · 2022: $2,430 · 2023: $300 · 2024: $1,467 · 2025: $2,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,060 · Grant: $1,667 · Travel and Lodging: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.40 |
| Grant | $1,666.67 |
| Travel and Lodging | $880.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $5,383.93 | 2020-2024 | |
| Smith+Nephew, INC. | $1,666.67 | 2025 | |
| Stryker Corporation | $1,389.98 | 2023-2025 | Gamma, Alphavent, Na |
| Medical Device Business Services, INC. | $1,132.21 | 2024-2025 | |
| Catalyst Orthoscience | $127.79 | 2024 | Catalyst Csr Shoulder System, R1 Reverse Shoulder System |
| Next Science LLC | $99.34 | 2024 | Blastx, Surgx, Xperience |
| Acera Surgical, INC. | $86.09 | 2024 | Restrata Wound Matrix |
| Saxum Surgical, INC. | $73.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Bugarinovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.